Cargando…

Hydrogen Gas Attenuates Hypoxic-Ischemic Brain Injury via Regulation of the MAPK/HO-1/PGC-1a Pathway in Neonatal Rats

Neonatal hypoxic-ischemic encephalopathy (HIE) is a leading cause of death in neonates with no effective treatments. Recent advancements in hydrogen (H(2)) gas offer a promising therapeutic approach for ischemia reperfusion injury; however, the impact of this approach for HIE remains a subject of de...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peipei, Zhao, Mingyi, Chen, Zhiheng, Wu, Guojiao, Fujino, Masayuki, Zhang, Chen, Zhou, Wenjuan, Zhao, Mengwen, Hirano, Shin-ichi, Li, Xiao-Kang, Zhao, Lingling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040418/
https://www.ncbi.nlm.nih.gov/pubmed/32104537
http://dx.doi.org/10.1155/2020/6978784
Descripción
Sumario:Neonatal hypoxic-ischemic encephalopathy (HIE) is a leading cause of death in neonates with no effective treatments. Recent advancements in hydrogen (H(2)) gas offer a promising therapeutic approach for ischemia reperfusion injury; however, the impact of this approach for HIE remains a subject of debate. We assessed the therapeutic effects of H(2) gas on HIE and the underlying molecular mechanisms in a rat model of neonatal hypoxic-ischemic brain injury (HIBI). H(2) inhalation significantly attenuated neuronal injury and effectively improved early neurological outcomes in neonatal HIBI rats as well as learning and memory in adults. This protective effect was associated with initiation time and duration of sustained H(2) inhalation. Furthermore, H(2) inhalation reduced the expression of Bcl-2-associated X protein (BAX) and caspase-3 while promoting the expression of Bcl-2, nuclear factor erythroid-2-related factor 2, and heme oxygenase-1 (HO-1). H(2) activated extracellular signal-regulated kinase and c-Jun N-terminal protein kinase and dephosphorylated p38 mitogen-activated protein kinase (MAPK) in oxygen-glucose deprivation/reperfusion (OGD/R) nerve growth factor-differentiated PC12 cells. Inhibitors of MAPKs blocked H(2)-induced HO-1 expression. HO-1 small interfering RNA decreased the expression of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and sirtuin 1 (SIRT1) and reversed the protectivity of H(2) against OGD/R-induced cell death. These findings suggest that H(2) augments cellular antioxidant defense capacity through activation of MAPK signaling pathways, leading to HO-1 expression and subsequent upregulation of PGC-1α and SIRT-1 expression. Thus, upregulation protects NGF-differentiated PC12 cells from OGD/R-induced oxidative cytotoxicity. In conclusion, H(2) inhalation exerted protective effects on neonatal rats with HIBI. Early initiation and prolonged H(2) inhalation had better protective effects on HIBI. These effects of H(2) may be related to antioxidant, antiapoptotic, and anti-inflammatory responses. HO-1 plays an important role in H(2)-mediated protection through the MAPK/HO-1/PGC-1α pathway. Our results support further assessment of H(2) as a potential therapeutic for neurological conditions in which oxidative stress and apoptosis are implicated.